S&P 500 7559.45 +0.21%
NASDAQ 26226.06 +0.07%
TASI 10808.43 -0.42%
Oil (WTI) 71.59 -0.68%
Oil (Brent) 76.06 -0.31%
VIX 15.59 -1.58%
Gold 4112.90 -0.67%
USD/SAR 3.75 +0.01%

Moderna, Inc.

MRNA · Healthcare · · USD
70.18 USD
0.00 (-8.33%)
● Updated 2026-07-10 17:08 Saudi Time ↻ Refresh
Short-term Mid-term Long-term

Fahodi Score STRONG BUY Short-term (Swing)

92
/ 100
Technical 100
Trend & RS 99
Momentum 99
Fundamental (0%) 67
Macro 71
Liquidity 34
ComponentScoreWeight
Technical 100.0 40%
Trend & RS 99.2 20%
Momentum 99.1 20%
Fundamental 66.7 0%
Macro 71.2 15%
Liquidity 34.4 5%

Trade Setup

Entry 69.75
Stop Loss 59.37 (14.9%)
Target 1 (1:1) 80.12 (+14.9%)
Target 2 (2:1) 90.50 (+29.8%)
ATR(14) 5.19 (7.4%)
Risk per Share 10.38
Reward:Risk 2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor Score Z Bar
Value 65.7 +0.63
Momentum 99.1 +1.97
Quality 18.2 -1.27
Composite 61.0

Quality Scores

Piotroski F-Score 3 /9 — Weak
1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover
Altman Z-Score 13.79 Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Fair Value

MetricStockSectorvs Peers
P/E Ratio N/A 22.0 Inline
P/B Ratio 3.8 4.0 Inline

Comparing against Healthcare median multiples.

Position Sizing — Kelly Criterion

4.8%
Recommended Size
57.92%
Full Kelly
28.96%
Half Kelly
5.0%
Max Cap (Moderate)

Kelly inputs derived from quant score 92/100. Estimated win rate 68%, avg win 10.5%, avg loss 3.2%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

RECOVERY Regime: RECOVERY (20% confidence) — position size reduced 4%

Signal Summary STRONG BUY

4
Bullish Signals
0
Bearish Signals
56.74
RSI(14)
6.5022
MACD

Relative Strength (RS) IMPROVING

97
/ 99
RS Rating
O'Neil PASS (≥80)
RS vs SPY ↑ RISING (+25.0% vs SPY 3M)
RS vs Sector OUTPERFORMING (Healthcare)
RS New High No (4d since high)
Sector Outperformance +32.7% (3M)
RS Line — stock / SPY (90 bars)
← older newer →
RS vs SPY 50-day SMA of RS
IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

IndicatorValueSignal
Rsi 56.74 NEUTRAL
Macd 6.5022 BULLISH
Ma Cross 55.19 / 42.39 GOLDEN CROSS
Trend Short ABOVE SMA50
Trend Long ABOVE SMA200
Bollinger MIDDLE
Volume 0.23x LOW

Key Levels

LevelPrice
52-Week High85.60
Bollinger Upper85.61
SMA(200)42.39
SMA(50)55.19
SMA(20)65.71
Current Price70.18
Bollinger Lower45.82
52-Week Low22.28
ATR(14)5.19

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKUP Confidence
100%
Acc: 0.0  |  Dist: 0.0  |  Markup: 2.0  |  Markdown: 0.0

Volume Spread Analysis (last 5 bars)

DateSignalVolDescription
2026-07-06 Normal 1.75x Normal bar — no special VSA pattern
2026-07-07 Normal 0.88x Normal bar — no special VSA pattern
2026-07-08 Normal 0.67x Normal bar — no special VSA pattern
2026-07-09 No Supply 0.45x Low volume, narrow spread, firm close — no selling pressure
2026-07-10 Normal 0.23x Normal bar — no special VSA pattern

Ichimoku Cloud NEUTRAL

LineValueStatus
Tenkan-sen (9) 75.95 Above Kijun
Kijun-sen (26) 65.45 Base line
Senkou A 70.70 Leading span A
Senkou B 64.64 Leading span B
Cloud 64.64 – 70.70 Bullish (Green)
Price vs Cloud 69.75 Inside Cloud
Chikou Span 49.06 Bullish
Alignment Score 3/4 NEUTRAL

TTM Squeeze & Divergences

TTM Squeeze

SQUEEZE OFF No squeeze Momentum: BULLISH FADING
BB: 45.82 – 85.61  |  KC: 57.29 – 74.14

Divergences (last 60 bars)

TypeIndicatorBars AgoStrength
Regular Bullish RSI 27

Anchored VWAP

VWAP: 46.61 Anchor: 2025-11-21 (52w Low) ABOVE AVWAP +49.6%

Heikin-Ashi Trend

BEARISH Full data via /api/advanced/MRNA

Valuation

MetricValue
Market Cap27.85B
P/E (TTM)N/A
Forward P/EN/A
P/B3.76
EPS-8.14

Financial Health

MetricValue
Revenue Growth2.6%
Profit Margin-1.4%
ROE-36.6%
Debt/Equity17.52
Current Ratio2.41
Dividend YieldN/A
Payout RatioN/A
Beta0.94

Trading Data

70.18
Open
70.18
Day High
70.18
Day Low
1.98M
Volume (0.3x avg)

Recent News (8)

Why Moderna (MRNA) Stock Is Trading Up Today
StockStory · 2026-07-09
Moderna (MRNA) Stock May Sit Above Fair Value Following Pipeline Expansion
Simply Wall St. · 2026-07-09
Moderna secures up to 24 million RSV vaccine dose contract with Europe
Pharmaceutical Technology · 2026-07-09
RBC Capital Raises its Price Target on Moderna (MRNA)
Insider Monkey · 2026-07-09
Will New Board Appointment And mRNA Flu Progress Change Moderna's (MRNA) Pipeline Diversification Narrative?
Simply Wall St. · 2026-07-09
Update: Dow Logs Worst Day in 4 Weeks Amid Renewed US-Iran Tensions
MT Newswires · 2026-07-08
US Equity Markets Mixed After Trump Warns of Additional Strikes on Iran
MT Newswires · 2026-07-08
Why Moderna Stock Is the S&P 500’s Big Loser Today
Barrons.com · 2026-07-08

Price Chart (90 Days)

Candlesticks (green=up, red=down) SMA 20 SMA 50 Bollinger Bands (upper/lower) Volume (green=buying, red=selling)
Powered by Fahodi Methodology. This is analytical output, not financial advice. Always do your own due diligence.  ·  Pipeline status  ·  Data: —